Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 3.05MCash and Equivalents
VS
Market
Sector
Industry
History
$ 3.01Close
$ 2.13 - $ 8.24 52-Week Range
Ticker Information
Ticker
BMRACompany Name
BIOMERICA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQBIOMERICA INC - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BMRA - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 9/30/2025 | $ 3.05M |
| 6/30/2025 | $ 2.4M |
| 3/31/2025 | $ 3.06M |
| 12/31/2024 | $ 2.37M |
| 9/30/2024 | $ 2.82M |
| 6/30/2024 | $ 4.17M |
| 3/31/2024 | $ 5.32M |
| 12/31/2023 | $ 7.13M |
| 9/30/2023 | $ 7.99M |
| 6/30/2023 | $ 9.72M |
Key Performance Insights, Last 5 Years
- BIOMERICA INC's latest trailing twelve months (TTM) CashnEq stands at $ 5.68M.
- Over the past 5 years, BIOMERICA INC's average CashnEq has been $ 5.3M.
- The median CashnEq for BIOMERICA INC during this period was $ 5.17M
- BIOMERICA INC reached its highest CashnEq over the past 5 years at $ 10.17M.
- The lowest CashnEq recorded by BIOMERICA INC in the same timeframe $ 2.37M
BIOMERICA INC's CashnEq vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq Benchmarks
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.BMRA - Cash and Equivalents, Last 5 years
$ 2.37M
Minimum
Dec 31, 2024
$ 10.17M
Maximum
Mar 31, 2022
$ 5.3M
Average
$ 5.17M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 98.92M with a standard deviation of $ 119.36M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.61K |
|---|---|
| min | $ 0 |
| max | $ 492.42M |
| average | $ 98.92M |
| median | $ 48.22M |
| std | $ 119.36M |